MedPath

To check Effectiveness of 2 chloroprocaine and bupivacaine for short duration Infraumbilical surgeries

Not Applicable
Not yet recruiting
Conditions
Infraumbilical short duration surgery
Registration Number
CTRI/2018/07/014932
Lead Sponsor
Dhondiram Dadu Kamble
Brief Summary

Spinal anaesthesia is safe and reliable technique for surgeries of lower abdomen and lower limbs. Nevertheless, some of the characteristics may limit its use for umbilical surgeries, including delayed ambulation, risk of urinary retention. So the choice of local anaesthetic is crucial in ambulatory settings. Short acting local anaesthetic may therefore represent a valid alternative like preservative free  isobaric 2 chloroprocaine.

Preservative free isobaric 2 chloroprocaine is shorter acting and without significant risk of Transient Neurological Symptoms with respect to hyperbaric lidocaine. The recovery is far earlier than bupivacaine and urinary retention is also not observed in most of the patients. Haemodynamic changes are also not much. So we think that chloroprocaine is better for short duration surgeries with better outcome.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Weight 50 to 70 kg ASA GRADE 1 AND 2.

Exclusion Criteria

Spine deformities Prolonged major surgeries Coagulation abnormalities.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Duration of anaesthesia an restriction of movementEnd of surgery | At 1.5 hrs after giving spinal | 2 hrs | 2.5 hrs
Secondary Outcome Measures
NameTimeMethod
Any complications like urinary retensionTransient Neurological Symptoms

Trial Locations

Locations (1)

civil hospital

🇮🇳

Sangli, MAHARASHTRA, India

civil hospital
🇮🇳Sangli, MAHARASHTRA, India
Dr Raviraj Dhondiram Kamble
Principal investigator
8983399475
drraviraj.mdanaesthesia@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.